MedAdvisor Past Earnings Performance

Past criteria checks 0/6

MedAdvisor has been growing earnings at an average annual rate of 17%, while the Healthcare Services industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 37.6% per year.

Key information

17.0%

Earnings growth rate

33.3%

EPS growth rate

Healthcare Services Industry Growth42.6%
Revenue growth rate37.6%
Return on equity-8.3%
Net Margin-4.5%
Last Earnings Update31 Dec 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How MedAdvisor makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CHIA:MDR Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 24104-5130
30 Sep 24113-2140
30 Jun 241221150
31 Mar 24116-4150
31 Dec 23109-9150
30 Sep 23104-10140
30 Jun 2398-11130
31 Mar 2396-8100
31 Dec 2293-570
30 Sep 2280-1150
30 Jun 2268-1730
31 Mar 2266-1630
31 Dec 2164-1430
30 Sep 2152-1430
30 Jun 2139-1430
31 Mar 2128-1340
31 Dec 2018-1260
30 Sep 2014-1160
30 Jun 2010-1060
31 Mar 209-950
31 Dec 199-940
30 Sep 199-850
30 Jun 198-850
31 Mar 198-750
31 Dec 187-750
30 Sep 187-650
30 Jun 187-440
31 Mar 186-440
31 Dec 176-440
30 Sep 175-440
30 Jun 174-330
31 Mar 173-420
31 Dec 162-420
30 Sep 162-410
30 Jun 161-310
31 Mar 161-210
31 Dec 152-110
30 Sep 152-110
30 Jun 152-100
30 Jun 141-100

Quality Earnings: MDR is currently unprofitable.

Growing Profit Margin: MDR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MDR is unprofitable, but has reduced losses over the past 5 years at a rate of 17% per year.

Accelerating Growth: Unable to compare MDR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.5%).


Return on Equity

High ROE: MDR has a negative Return on Equity (-8.3%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/09 11:59
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MedAdvisor Limited is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anubhav SaxenaBell Potter
Thomas WakimBell Potter
Elyse ShapiroCanaccord Genuity